We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Analysis of Human Tear Proteins in Children

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00473278
First Posted: May 15, 2007
Last Update Posted: January 30, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Colorado, Denver
  Purpose
The significance of our study is in the importance of understanding the quality and quantity of proteins in the human tear film, and any unique aspects of tears in children. This pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.

Condition
Eye Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Analysis of Human Tear Proteins in Children: A Pilot Study to Describe the Tear Film Proteome of Pediatric Patients Undergoing Ophthalmic Examination.

Resource links provided by NLM:


Further study details as provided by University of Colorado, Denver:

Primary Outcome Measures:
  • Proteome of Human Tears [ Time Frame: Single Exam ]

Enrollment: 2
Study Start Date: January 2007
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
children less than 18 years of age
Criteria

Inclusion Criteria:

  • Less than 18 years of age
  • A parent or legal guardian provide written informed consent to participate
  • Able to cooperate with tear sample collection, or a previously planned sedation for other medical purposes

Exclusion Criteria:

  • Age greater than or equal to 18 years
  • Patients' parents or legal guardians who refuse to sign study consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00473278


Locations
United States, Colorado
The Childrens Hospital
Denver, Colorado, United States, 80218
Sponsors and Collaborators
University of Colorado, Denver
Investigators
Principal Investigator: Malik Y. Kahook, MD Rocky Mountain Lions Eye Institute
  More Information

Responsible Party: University of Colorado, Denver
ClinicalTrials.gov Identifier: NCT00473278     History of Changes
Other Study ID Numbers: 06-1067
First Submitted: May 11, 2007
First Posted: May 15, 2007
Last Update Posted: January 30, 2013
Last Verified: January 2013

Keywords provided by University of Colorado, Denver:
tear protein

Additional relevant MeSH terms:
Eye Diseases


To Top